Vikram has over 30 year of pharmacovigilance experience that started with an MD degree from Pune University that led to 11 years practicing Anesthesiology followed by Infectious Disease and Epidemiology. During his time in UK, he received a post graduate degree from Edinburgh University in Community Medicine. Vikram’s first industry job was at Sandoz in 1991 which became Novartis in Basel Switzerland. In 1998 he moved to the US to Zeneca Pharmaceuticals where he led mainly CNS drugs (Seroquel) and later was involved with all therapeutic areas. After leaving AZ, Vikram served as the Global head of safety at Jazz pharmaceuticals for a short period of 10 months and then moved on to Daiichi Sankyo as Head of US Safety from 2016 to 2020.
Vikram Dev, MD
Head of Drug Safety and Pharmacovigilance